CBAY - Stifel likes Viking Therapeutics in premarket analyst action June, 25 2019 08:25 AM CymaBay Therapeutics Inc. Medivir AB (OTC:MVRBF) initiated with Buy rating at H.C. Wainwright.More news on: Medivir AB (publ), Cassava Sciences, Inc., CymaBay Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...